Recent data suggests that aspirin may be effective for reducing cancer deaths in addition to preventing heart attacks, raising the question whether the combined health benefits outweigh the risks of gastrointestinal bleeding and stroke for middle-aged men, researchers announced Wednesday.
Bayer Healthcare last week reported it has discontinued certain advertising claims made in broadcast advertising for Alka-Seltzer Plus Severe Sinus Congestion and Cough, a sinus medication, following a challenge made by Procter & Gamble to the National Advertising Division, an investigative unit of the advertising industry’s system of self-regulation.
UrgentRx's fast powder OTC treatments are beginning to show up at the check-stand. As a brand offering, it represents a unique delivery format with unique merchandising opportunities. DSN sought out founder and president Jordan Eisenberg for the details.
Patients once considered "aspirin resistant" may not be resistant to aspirin after all, according to a study published online by Circulation, the journal of the American Heart Association. Rather, the protective coating around the aspirin to prevent stomach issues may be delaying the absorption of aspirin, leading clinicians to believe that patients are aspirin resistant.
Recent research from the Rothman Institute at Jefferson has shown aspirin to be just as effective in preventing clots — specifically pulmonary emboli, life-threatening blood clots that can develop in the arteries of the lungs following joint replacement surgery — Thomas Jefferson University announced Wednesday.
Aspirin has the potential to block tumor growth in certain patients with colorectal cancer, according to an editorial in the Oct. 25, 2012 issue of the New England Journal of Medicine by a University of Alabama at Birmingham oncologist.
Bayer HealthCare's Consumer Care Division on Tuesday introduced Bayer Migraine Formula, an over-the-counter medication designed to relieve migraine pain and accompanying symptoms like nausea, phonophobia (sound sensitivity) and photophobia (light sensitivity) through a formulation of aspirin, acetaminophen and caffeine.
Men who have been treated for prostate cancer, either with surgery or radiation, could benefit from taking aspirin regularly, according to a multicenter study published in Tuesday's issue of the Journal of Clinical Oncology.
Bayer has been stepping up its game behind its Bayer Advanced Aspirin brand in an attempt to recreate its brand identity from a healthy heart supplement for people who’ve had a heart attack to what Bayer Aspirin had been in its heyday: the internal analgesic of choice.
A large new observational study published Friday found more evidence of an association between daily aspirin use and modestly lower cancer mortality, but suggested any reduction may be smaller than that observed in a recent analysis. The study appeared online in the Journal of the National Cancer Institute.
To encourage consumers to rethink aspirin for pain relief — according to a recent Bayer survey, only 8% of respondents reported taking aspirin more often that other OTC pain relievers — Bayer on Tuesday issued the Fast Relief Challenge and is giving away 100,000 bottles of Bayer Advanced Aspirin so consumers can put the pain reliever to the test.
Annapolis, Md.-based St. Joseph Consumer Health last week unveiled a new St. Joseph-branded line of cough cold products formulated for patients with high blood pressure at the ECRM Cough & Cold and Allergy EPPS.
A large European study released Tuesday found that daily aspirin use is linked to an increased risk of age-related macular degeneration, a disease that can damage the central vision that is essential for reading and driving.
Aspirin taken within five days before cardiac surgery is associated with a significant decrease in the risk of major postoperative complications, including renal failure, an intensive care unit stay, and even early death (30-day mortality), according to findings from an observational cohort study by researchers at Thomas Jefferson University and the University of California Davis Medical Center that are set to appear in the journal Annals of Surgery.
The American Pain Foundation on Wednesday launched new information and resources on pain medication safety for acetaminophen and nonsteroidal anti-inflammatory drugs as part of its PainSafe educational initiative.
An investigational drug made by Bristol-Myers Squibb works better than aspirin in reducing the risk of complications in certain patients with heart rhythm problems, according to results of a late-stage clinical trial published in the New England Journal of Medicine.